Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate

Vaccine

Volumn 24, Issue 33-34, 2006, Pages 5997-6008

  Bonnet, Sarah ^a   Pêtres, Stéphane ^a   Holm, Inge ^a   Fontaine, Thierry ^a   Rosario, Sandrine ^a   Roth, Charles ^a   Longacre, Shirley ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Glycosyl phosphtidyl inositol (GPI); Malaria vaccine; Merozoite surface protein 1; Plasmodium falciparum

Indexed keywords

GLYCAN; GLYCOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; INOSITOL; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; DRUG PURIFICATION; ENDOPLASMIC RETICULUM; GEL FILTRATION; IMMUNOSTIMULATION; INSECT CELL; MASS SPECTROMETRY; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; CELL LINE; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GENETIC VECTORS; MALARIA VACCINES; MASS SPECTROMETRY; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SOLUBILITY; SPODOPTERA;

EID: 33746097773     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.069     Document Type: Article

References (66)

1. Gerold P., Schofield L., Blackman M.J., Holder A.A., and Schwarz R.T. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol Biochem Parasitol 75 2 (1996) 131-143
2. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., and Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172 1 (1990) 379-382
3. Holder A.A., and Blackman M.J. What Is the Function of Msp-I on the malaria merozoite. Parasitol Today 10 5 (1994) 182-184
4. Chitarra V., Holm I., Bentley G.A., Petres S., and Longacre S. The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. Mol Cell 3 4 (1999) 457-464
5. Pizarro J.C., Chitarra V., Verger D., Holm I., Pêtres S., Dartevelle S., et al. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. J Mol Biol 328 5 (2003) 1091-1103
6. O'Donnell R.A., de Koning-Ward T.F., Burt R.A., Bockarie M., Reeder J.C., Cowman A.F., et al. Antibodies against merozoite surface protein (msp)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193 12 (2001) 1403-1412
7. O'Donnell R.A., Saul A., Cowman A.F., and Crabb B.S. Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species. Nat Med 6 1 (2000) 91-95
8. Jongwutiwes S., Tanabe K., and Kanbara H. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates. Mol Biochem Parasitol 59 1 (1993) 95-100
9. Kang Y., and Long C.A. Sequence heterogeneity of the C-terminal. Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol Biochem Parasitol 73 1-2 (1995) 103-110
10. Kaneko O., Kimura M., Kawamoto F., Ferreira M.U., and Tanabe K. Plasmodium falciparum, allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Exp Parasitol 86 1 (1997) 45-57
11. Qari S.H., Shi Y.P., Goldman I.F., Nahlen B.L., Tibayrenc M., and Lal A.A. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol 92 2 (1998) 241-252
12. Hughes M.K., and Hughes A.L. Natural selection on Plasmodium surface proteins. Mol Biochem Parasitol 71 1 (1995) 99-113
13. Riley E.M., Allen S.J., Wheeler J.G., Blackman M.J., Bennett S., Takacs B., et al. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 14 3 (1992) 321-337
14. Egan A.F., Morris J., Barnish G., Allen S., Greenwood B.M., Kaslow D.C., et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173 3 (1996) 765-769
15. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., et al. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun 64 7 (1996) 2716-2723
16. Shai S., Blackman M.J., and Holder A.A. Epitopes in the 19 kDa fragment of the Plasmodium falciparum major merozoite surface protein-1 (PfMSP-1(19)) recognized by human antibodies. Parasite Immunol 17 5 (1995) 269-275
17. Branch O.H., Udhayakumar V., Hightower A.W., Oloo A.J., Hawley W.A., Nahlen B.L., et al. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants, associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg 58 2 (1998) 211-219
18. Perraut R., Marrama L., Diouf B., Fontenille D., Tall A., Sokhna C., et al. Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure. J Infect Dis 188 12 (2003) 1940-1950
19. Perraut R., Marrama L., Diouf B., Sokhna C., Tall A., Nabeth P., et al. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. J Infect Dis 191 2 (2005) 264-271
20. Egan A.F., Burghaus P., Druilhe P., Holder A.A., and Riley E.M. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol 21 3 (1999) 133-139
21. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., et al. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J Immunol 173 1 (2004) 666-672
22. Chang S.P., Case S.E., Gosnell W.L., Kramer K.J., Tam L.Q., Hashiro C.Q., et al. A recombinant Baculovirus 42-kilodalton c-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect Immun 64 1 (1996) 253-261
23. Perera K.L., Handunnetti S.M., Holm I., Longacre S., and Mendis K. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect Immun 66 4 (1998) 1500-1506
24. Stowers A.W., Chen Lh L.H., Zhang Y., Kennedy M.C., Zou L., Lambert L., et al. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum. Proc Natl Acad Sci USA 99 1 (2002) 339-344
25. Darko C.A., Angov E., Collins W.E., Bergmann-Leitner E.S., Girouard A.S., Hitt S.L., et al. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect Immun 73 1 (2005) 287-297
26. Kumar S., Yadeva A., Keister D.B., Tian J.H., Ohl M., Perdue-Greenfield K.A., et al. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol Med 1 3 (1995) 325-332
27. Egan A.F., Blackman M.J., and Kaslow D.C. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Infect Immun 68 3 (2000) 1418-1427
28. Kumar S., Collins W., Egan A., Yadeva A., Garroud O., Blackman M.J., et al. Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. Infect Immun 68 4 (2000) 2215-2223
29. Stowers A.W., Cioce V., Shimp R.L., Lawson M., Hui G., Muratova O., et al. Efficacy of Two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect Immun 69 3 (2001) 1536-1546
30. Burghaus P.A., Wellde B.T., Hall T., Richards R.L., Egan A.F., Riley E.M., et al. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect Immun 64 9 (1996) 3614-3619
31. Ferguson M.A., Brimacombe J.S., Cottaz S., Field R.A., Guther L.S., Homans S.W., et al. Glycosyl-phosphatidylinositol molecules of the parasite and the host. Parasitology 108 Suppl. (1994) S45-S54
32. Schofield L., and Tachado S.D. Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa. Immunol Cell Biol 74 6 (1996) 555-563
33. Schofield L., and Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 177 1 (1993) 145-153
34. Tachado S.D., Gerold P., McConville M.J., Baldwin T., Quilici D., Schwarz R.T., et al. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol 156 5 (1996) 1897-1907
35. Schofield L., Novakovic S., Gerold P., Schwarz R.T., McConville M.J., and Tachado S.D. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156 5 (1996) 1886-1896
36. Schofield L., Novakovic S., Gerold P., Schwarz R.T., McConville M.J., and Tachado S.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283 5399 (1999) 225-229
37. Naik R.S., Branch O.H., Woods A.S., Vijaykumar M., Perkins D.J., Nahlen B.L., et al. Glycosylphosphatidylinositol anchors of Plasmodium falciparum, molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med 192 11 (2000) 1563-1576
38. de Souza J.B., Todd J., Krishegowda G., Gowda D.C., Kwiatkowski D., and Riley E.M. Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. Infect Immun 70 9 (2002) 5045-5051
39. Boutlis C.S., Gowda D.C., Naik R.S., Maguire G.P., Mgone C.S., Bockarie M.J., et al. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols. inverse association with tolerance of Parasitemia in Papua New Guinean children and adults. Infect Immun 70 9 (2002) 5052-5057
40. Perraut R., Diatta B., Marrama L., et al. Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. Microbes Infect 7 4 (2005) 682-687
41. Schofield L., Hewitt M.C., Evans K., Siomos M.A., and Seeberger P.H. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418 6899 (2002) 785-789
42. Holm I., Nato F., Mendis K.N., and Longacre S. Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response. Mol Biochem Parasitol 89 2 (1997) 313-319
43. Longacre S., Mendis K.N., and David P.H. Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. Mol Biochem Parasitol 64 2 (1994) 191-205
44. Fergusson M.A.J. In lipid modification of proteins. In: Turner A.J., and Hooper N.M. (Eds). A practical approach. (1992), IRL press, Oxford 191-230
45. Kamerling J.P., Gerwig G.J., Vliegenthart J.F., and Clamp J.R. Characterization by gas-liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem J 151 3 (1975) 491-495
46. Ferguson M.A.J. GPI membrane anchors isolation and analysis. In: Fukuda M., and Kobata (Eds). In glycobiology, a practical approach (1993), IRL Press, Oxford 349-383
47. Chang S.P., Kramer K.J., Yamaga K.M., Kato A., Case S.E., and Siddiqui W.A. Plasmodium falciparum, gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Exp Parasitol 67 1 (1988) 1-11
48. Miller L.H., Roberts T., Shahabuddin M., and McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 59 1 (1993) 1-14
49. Altmann F., Staudacher E., Wilson I.B., and Marz L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J 16 2 (1999) 109-123
50. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110 5 (2002) 597-603
51. Nagarajan S., and Selvaraj P. Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells, protein transfer onto tumor cells. Protein Expr Purif 17 2 (1999) 273-281
52. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 3 (1992) 533-544
53. McHugh R.S., Ahmed S.N., Wang Y.C., Sell K.W., and Selvaraj P. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci USA 92 17 (1995) 8059-8063
54. Quakyi I.A., Currier J., Fell A., Taylor D.W., Roberts T., Houghten R.A., et al. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. J Immunol 153 5 (1994) 2082-2092
55. Parra M., Hui G., Johnson A.H., Berzofsky J.A., Roberts T., Quakiyi I.A., and Taylor D.W. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1. Infect Immun 68 5 (2000) 2685-2691
56. Guevara Patino J.A., Holder A.A., McBride J.S., and Blackman M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med 186 10 (1997) 1689-1699
57. Wilson I.B., Harthill J.E., Mullin N.P., Ashford D.A., and Altmann F. Core alpha1,3-fucose is a key part of the epitope recognized by antibodies reacting against plant N-linked oligosaccharides and is present in a wide variety of plant extracts. Glycobiology 8 7 (1998) 651-661
58. Altmann F., Schwihla H., Staudacher E., Glossl J., and Marz L. Insect cells contain an unusual, membrane-bound ß-N-acetylglucosamineidase probably involved in the processing of protein N-glycans. J Biol Chem 270 (1995) 17344-17349
59. Davies A., and Morgan B.P. Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector. Biochem J 295 Part 3 (1993) 889-896
60. Kedees M.H., Gerold P., Azzouz N., Blaschke T., Shams-Eldrin H., Muhlberger E., et al. Processing and localisation of a GPI-anchored Plasmodium falciparum surface protein expressed by the baculovirus system. Eur J Cell Biol 79 1 (2000) 52-61
61. Murphy V.F., Rowan W.C., Page M.J., and Holder A.A. Expression of hybrid malaria antigens in insect cells and their engineering for correct folding and secretion. Parasitology 100 Part 2 (1990) 177-183
62. Delahunty M.D., Stafford F.J., Yuan L.C., Shaz D., and Bonifacino J.S. Uncleaved signals for glycosylphosphatidylinositol anchoring cause retention of precursor proteins in the endoplasmic reticulum. J Biol Chem 268 (1993) 12017-12027
63. Eisenhaber B., Maurer-Stroh S., Novatchkova M., Schneider G., and Eisenhaber F. Enzymes and auxiliary factors for GPI lipid anchor biosynthesis and post-translational transfer to proteins. Bioessays 25 4 (2003) 367-385
64. Kennard M.L., Shimizu K.Y., Gabathuler R., Rothenberger S., Theilmann D., and Jefferies W.A. Expression of cell surface GPI-anchored human p97 in baculovirus infected insect cells. Biotech Bioeng 55 (1997) 41-53
65. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 1 (2001) 416-423
66. Krishnegowda G., Hajjar A.M., Zhu J., Douglass E.J., Uematsu S., Akira S., et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum, cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280 9 (2005) 8606-8616